ARVN vs KMDA: stock comparison and AI forecast
Arvinas, Inc. (ARVN) and Kamada Ltd (KMDA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ARVN Arvinas, Inc.
- Market Cap
- $428M
- P/E Ratio
- 6.0x
- Size
- small-cap
- AI Forecast
KMDA Kamada Ltd
- Market Cap
- $418M
- P/E Ratio
- 11.3x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ARVN and KMDA have similar market capitalizations ($428M and $418M).
- ARVN trades at 6.0 times trailing earnings, KMDA at 11.3 times.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ARVN | KMDA |
|---|---|---|
| Market Cap | $428M | $418M |
| P/E Ratio | 5.95x | 11.33x |
| P/B Ratio | 0.83x | – |
| EPS | $1.10 | $0.64 |
| Book Value/Share | $7.86 | – |
| Revenue/Share | $3.97 | $5.48 |
| FCF/Share | $-2.44 | – |
Profitability & Margins
| Metric | ARVN | KMDA |
|---|---|---|
| ROE | – | 11.6% |
| ROA | – | 8.2% |
| ROIC | -6.2% | – |
| Gross Margin | – | 43.0% |
| Operating Margin | -12.9% | 15.5% |
| Net Margin | – | 9.8% |
| EBT Margin | -3.4% | 13.3% |
| Tax Rate | -6.7% | 12.7% |
Financial Health
| Metric | ARVN | KMDA |
|---|---|---|
| Current Ratio | 8.39x | – |
| D/E Ratio | 0.18x | – |
| Financial Leverage | 1.18x | 1.41x |
| Interest Coverage | 10.8x | – |
| Working Capital | $518M | – |
Cash Flow
| Metric | ARVN | KMDA |
|---|---|---|
| Operating Cash Flow | -$158M | $43M |
| Free Cash Flow | -$160M | – |
| Capital Spending | -$2M | – |
| OCF Growth YoY | – | -48.2% |
| FCF/Sales | -61.5% | – |
| CapEx/Sales | 0.6% | – |
Operational Efficiency
| Metric | ARVN | KMDA |
|---|---|---|
| Asset Turnover | 0.43x | 0.84x |
| Receivables Turnover | 144.3x | – |
| Inventory Turnover | – | 2.1x |
| Fixed Assets Turnover | 56.5x | 7.6x |
| Days Sales Outstanding | 3 days | – |
| Days Inventory | – | 172 days |
| Payables Period | – | 47 days |
Income Statement
| Metric | ARVN | KMDA |
|---|---|---|
| Total Revenue | $260M | $316M |
| Operating Income | -$34M | $49M |
| Net Income | – | $31M |
| R&D Expense | $221M | $23M |
| Cost of Goods Sold | – | $180M |
Dividend & Shareholder Information
| Metric | ARVN | KMDA |
|---|---|---|
| Shares Outstanding | 65M | 58M |
| EPS Growth | – | 45.5% |
ARVN vs KMDA: stock comparison and AI forecast
Which is bigger, ARVN or KMDA?
ARVN and KMDA have similar market capitalizations ($428M and $418M).
Which is cheaper on earnings, ARVN or KMDA?
ARVN trades at 6.0 times trailing earnings, KMDA at 11.3 times.
Which one does Intratio's AI model rank higher, ARVN or KMDA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.